- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in dcgi
DCGI Gives Emergency Use Nod To SII's Covovax For 12-17 Years Age Group
It is the fourth vaccine to receive the regulator's nod for use among those below 18 years
Read More
Natco Pharma Signs Agreement With MPP To Sell Molnupiravir Capsules
Natco Pharma Ltd said it has signed a non-exclusive license agreement with the Medicines Patent Pool (MPP), Switzerland to manufacture and sell Molnupiravir capsules 200 mg for treatment of COVID-19.
Read More
Govt Expert Panel Recommends Regular Market Approval For Covishield, Covaxin
Pharma companies Serum Institute of India (SII) and Bharat Biotech had submitted applications to the Drugs Controller General of India (DCGI) seeking regular market authorisation for their respective COVID-19 vaccines Covishield and Covaxin.
Read More
Stempeutics Gets DCGI Nod For Phase 3 Trial For COVID Treatment
The company will be using its stem cell product, Stempeucel, for conducting the label extension Phase 3 clinical trial.
Read More
After Serum, Bharat Biotech Seeks Regular Marketing Approval For Covaxin
DCGI had asked for some more information following which Singh last week submitted a response along with all desired data and information to DCGI.
Read More
Pharma Firms To Roll Out Anti-Covid Pill As DCGI Approves Emergency Use
They plan to market the capsules under their respective brands and make them available at all leading pharmacies and COVID-treatment centres across the country.
Read More
Cadila Healthcare Gets DCGI Nod To Conduct Phase III Trials For Two-Dose COVID Vaccine
Shares of Cadila Healthcare Ltd were trading at Rs 563.95 per scrip on BSE, up 0.29 percent from their previous close
Read More
Novavax, SII Apply To WHO For Emergency Use Listing Of COVID Vaccine
The application to WHO is based on the companies' previous regulatory submission to the Drugs Controller General of India (DCGI), Novavax Inc said in a statement.
Read More
Mankind Pharma Gets DRDO Nod To Manufacture, Market Covid Drug 2-DG
The clinical trials for 2-DG were conducted by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO, in association with Dr Reddy’s Laboratories
Read More
Johnson & Johnson Exploring Ways To Accelerate Delivery Of Its COVID Vaccine In India
The company also said as per a recent announcement by the Indian drug regulator, there is no longer a need to conduct bridging clinical trials of COVID-19 vaccines in India.
Read More
Sun Pharma To Launch Complete Range Of Generic Anti-Epilepsy Drug
Brivaracetam belongs to the class of anti-epileptic drugs (AEDs) which have a unique or different mechanism of action compared to the existing treatment options. It has fast onset of action and promising efficacy.
Read MoreNew Thermo Fisher Scientific Manufacturing Facility to produce reliable COVID-19 testing kits in India for India
New Thermo Fisher Scientific Manufacturing Facility to produce reliable COVID-19 testing kits in India for India
Read MoreEnzene Biosciences Ltd. obtains marketing authorization for its first biosimilar molecule in India
Enzene Biosciences Ltd. obtains marketing authorization for its first biosimilar molecule in India
Read MoreBharat Biotech seeks DCGI's nod to conduct trials of nasal COVID-19 vaccine
Bharat Biotech seeks DCGI's nod to conduct trials of nasal COVID-19 vaccine
Read MoreOur goal is to provide global access of Covaxin to needy population: Dr Ella
Our goal is to provide global access of Covaxin to needy population: Dr Ella
Read More